vs
Side-by-side financial comparison of MICROVISION, INC. (MVIS) and 60 DEGREES PHARMACEUTICALS, INC. (SXTP). Click either name above to swap in a different company.
60 DEGREES PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($303.4K vs $223.0K, roughly 1.4× MICROVISION, INC.). On growth, 60 DEGREES PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (25.6% vs -86.5%). 60 DEGREES PHARMACEUTICALS, INC. produced more free cash flow last quarter ($-1.8M vs $-59.4M). Over the past eight quarters, 60 DEGREES PHARMACEUTICALS, INC.'s revenue compounded faster (69.4% CAGR vs -51.7%).
MicroVision Inc. is a technology company specializing in advanced LiDAR sensors, miniature display solutions, and perception software. Its core products serve automotive ADAS, augmented reality devices, consumer electronics, and industrial automation markets, delivering high-precision, low-power sensing technologies for next-generation smart applications.
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
MVIS vs SXTP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $223.0K | $303.4K |
| Net Profit | — | $-1.4M |
| Gross Margin | — | 60.2% |
| Operating Margin | — | -632.0% |
| Net Margin | — | -474.2% |
| Revenue YoY | -86.5% | 25.6% |
| Net Profit YoY | -21.2% | 29.7% |
| EPS (diluted) | — | $-8.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $223.0K | $303.4K | ||
| Q3 25 | $241.0K | $437.6K | ||
| Q2 25 | $155.0K | $100.9K | ||
| Q1 25 | $589.0K | $163.6K | ||
| Q4 24 | $1.6M | $241.6K | ||
| Q3 24 | $190.0K | $135.3K | ||
| Q2 24 | $1.9M | $125.0K | ||
| Q1 24 | $956.0K | $105.7K |
| Q4 25 | — | $-1.4M | ||
| Q3 25 | $-14.2M | $-2.3M | ||
| Q2 25 | $-14.2M | $-1.7M | ||
| Q1 25 | $-28.8M | $-1.9M | ||
| Q4 24 | $-31.2M | $-2.0M | ||
| Q3 24 | $-15.5M | $-2.2M | ||
| Q2 24 | $-23.9M | $-4.2M | ||
| Q1 24 | $-26.3M | $430.5K |
| Q4 25 | — | 60.2% | ||
| Q3 25 | — | -22.9% | ||
| Q2 25 | — | 50.4% | ||
| Q1 25 | 6.6% | 55.2% | ||
| Q4 24 | -149.5% | 51.1% | ||
| Q3 24 | — | 17.4% | ||
| Q2 24 | 18.2% | 28.3% | ||
| Q1 24 | -33.6% | 38.1% |
| Q4 25 | — | -632.0% | ||
| Q3 25 | -5278.4% | -531.4% | ||
| Q2 25 | -9455.5% | -1590.0% | ||
| Q1 25 | -2383.7% | -1168.4% | ||
| Q4 24 | -1119.5% | -854.7% | ||
| Q3 24 | -8266.3% | -1566.0% | ||
| Q2 24 | -1296.4% | -3351.8% | ||
| Q1 24 | -2793.9% | -1270.4% |
| Q4 25 | — | -474.2% | ||
| Q3 25 | -5899.2% | -529.3% | ||
| Q2 25 | -9180.0% | -1717.7% | ||
| Q1 25 | -4886.1% | -1147.4% | ||
| Q4 24 | -1888.2% | -846.3% | ||
| Q3 24 | -8166.8% | -1596.4% | ||
| Q2 24 | -1259.5% | -3339.0% | ||
| Q1 24 | -2752.4% | 407.4% |
| Q4 25 | — | $-8.26 | ||
| Q3 25 | $-0.05 | $-0.66 | ||
| Q2 25 | $-0.06 | $-1.25 | ||
| Q1 25 | $-0.12 | $-1.56 | ||
| Q4 24 | $-0.15 | $-51.96 | ||
| Q3 24 | $-0.07 | $-2.92 | ||
| Q2 24 | $-0.11 | $-21.12 | ||
| Q1 24 | $-0.13 | $1.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.9M | $2.8M |
| Total DebtLower is stronger | $19.2M | $150.0K |
| Stockholders' EquityBook value | $55.5M | $3.5M |
| Total Assets | $103.1M | $5.4M |
| Debt / EquityLower = less leverage | 0.35× | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.9M | $2.8M | ||
| Q3 25 | $99.5M | $4.1M | ||
| Q2 25 | $91.4M | $2.0M | ||
| Q1 25 | $69.0M | $3.5M | ||
| Q4 24 | $74.7M | $3.4M | ||
| Q3 24 | $43.2M | $5.0M | ||
| Q2 24 | $56.6M | $1.6M | ||
| Q1 24 | $73.1M | — |
| Q4 25 | $19.2M | $150.0K | ||
| Q3 25 | $29.0M | $150.0K | ||
| Q2 25 | $32.3M | $150.0K | ||
| Q1 25 | $30.1M | $150.0K | ||
| Q4 24 | $33.0M | $150.0K | ||
| Q3 24 | — | $150.0K | ||
| Q2 24 | — | $150.0K | ||
| Q1 24 | — | $150.0K |
| Q4 25 | $55.5M | $3.5M | ||
| Q3 25 | $90.7M | $4.4M | ||
| Q2 25 | $77.1M | $2.4M | ||
| Q1 25 | $53.2M | $4.1M | ||
| Q4 24 | $48.8M | $4.0M | ||
| Q3 24 | $65.9M | $6.0M | ||
| Q2 24 | $78.7M | $3.0M | ||
| Q1 24 | $93.8M | $7.2M |
| Q4 25 | $103.1M | $5.4M | ||
| Q3 25 | $150.8M | $6.7M | ||
| Q2 25 | $140.6M | $4.2M | ||
| Q1 25 | $116.7M | $6.0M | ||
| Q4 24 | $121.2M | $5.8M | ||
| Q3 24 | $88.3M | $7.4M | ||
| Q2 24 | $103.4M | $4.3M | ||
| Q1 24 | $124.2M | $8.4M |
| Q4 25 | 0.35× | 0.04× | ||
| Q3 25 | 0.32× | 0.03× | ||
| Q2 25 | 0.42× | 0.06× | ||
| Q1 25 | 0.57× | 0.04× | ||
| Q4 24 | 0.68× | 0.04× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.05× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-58.7M | $-1.7M |
| Free Cash FlowOCF − Capex | $-59.4M | $-1.8M |
| FCF MarginFCF / Revenue | -26636.3% | -584.2% |
| Capex IntensityCapex / Revenue | 304.5% | 26.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-103.1M | $-7.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-58.7M | $-1.7M | ||
| Q3 25 | $-16.5M | $-2.1M | ||
| Q2 25 | $-12.7M | $-1.5M | ||
| Q1 25 | $-14.1M | $-1.6M | ||
| Q4 24 | $-15.1M | $-1.6M | ||
| Q3 24 | $-14.1M | $-1.7M | ||
| Q2 24 | $-18.6M | $-1.2M | ||
| Q1 24 | $-20.8M | $-1.1M |
| Q4 25 | $-59.4M | $-1.8M | ||
| Q3 25 | $-16.6M | $-2.1M | ||
| Q2 25 | $-12.9M | $-1.5M | ||
| Q1 25 | $-14.2M | $-1.6M | ||
| Q4 24 | $-15.2M | — | ||
| Q3 24 | $-14.1M | $-1.7M | ||
| Q2 24 | $-18.8M | — | ||
| Q1 24 | $-20.9M | — |
| Q4 25 | -26636.3% | -584.2% | ||
| Q3 25 | -6894.6% | -484.2% | ||
| Q2 25 | -8346.5% | -1483.6% | ||
| Q1 25 | -2410.4% | -978.3% | ||
| Q4 24 | -918.7% | — | ||
| Q3 24 | -7421.1% | -1252.8% | ||
| Q2 24 | -989.5% | — | ||
| Q1 24 | -2183.4% | — |
| Q4 25 | 304.5% | 26.3% | ||
| Q3 25 | 53.1% | 2.3% | ||
| Q2 25 | 134.2% | 46.9% | ||
| Q1 25 | 16.8% | 1.6% | ||
| Q4 24 | 6.2% | — | ||
| Q3 24 | 4.7% | 10.2% | ||
| Q2 24 | 8.7% | — | ||
| Q1 24 | 11.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -2.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
